Q1 earnings surprise and renewed analyst attention

Colgate-Palmolive (CL) recently reported Q1 results with both revenue and earnings ahead of analyst expectations, prompting fresh attention on the stock as you consider how its fundamentals compare after the surprise.

The share price has moved around Q1 and dividend news, with a 30-day share price return of 2.70% and a year to date share price gain of 13.44%, while the 1-year total shareholder return is slightly down 0.96%, hinting at improving but still cautious momentum.

If strong quarterly updates like Colgate-Palmolive's have you thinking about other potential ideas, this is a good moment to scan 19 top founder-led companies.

With Q1 results ahead of expectations, a one-year return that is slightly down, and an intrinsic value estimate showing roughly a 27% gap, the question now is whether Colgate-Palmolive is still undervalued or if the market is already pricing in future growth.

Most Popular Narrative: 9% Undervalued

Against a last close of $88.13, the most followed narrative pegs Colgate-Palmolive's fair value closer to $96.68, putting the recent Q1 beat in a wider multi year context.

Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll out of complementary products across 75 markets, are set to capture increased value from emerging middle class consumers and rising health/hygiene awareness globally, which supports top line organic sales acceleration and improved pricing power.

Want to see what sits behind that gap to fair value? The narrative leans on measured revenue growth, higher margins, and a richer earnings profile than today.

Result: Fair Value of $96.68 (UNDERVALUED)

However, the narrative also hinges on input costs and consumer demand, with higher oil based materials and cautious shoppers potentially pressuring margins and slowing category growth.

Another View: P/E Tells A Different Story

While the most followed narrative and SWS fair value model point to Colgate-Palmolive trading about 27% below fair value, the current P/E of 33.8x looks steep against peers at 20.9x and a fair ratio of 23.6x. That gap suggests valuation risk rather than a clear bargain, so which signal do you trust more?

For a closer look at how this richer P/E compares across the sector, and the fair ratio the market could move toward, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of risks and rewards feels finely balanced, use the latest numbers to form a clear stance for yourself and move quickly by weighing up the 3 key rewards and 3 important warning signs.

Looking for more investment ideas?

Do not stop at one stock when plenty of other opportunities could fit your style. Use the Simply Wall St Screener to quickly surface ideas that match your criteria.

• Target potential bargains backed by solid fundamentals by scanning 51 high quality undervalued stocks before prices fully reflect their quality.
• Prioritize resilience and capital protection by reviewing companies in the 65 resilient stocks with low risk scores so sudden shocks do not catch you off guard.
• Spot under-the-radar opportunities with strong metrics by checking the screener containing 21 high quality undiscovered gems that many investors may be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.